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Abstract
The biochemistry of a system made up of three kinds of cell is virtually impossible to
work out without the use of in silico models. Here, we deal with homeostatic
balance phenomena from a metabolic point of view and we present a new
computational model merging three single-cell models, already available from our
research group: the first model reproduced the metabolic behaviour of a
hepatocyte, the second one represented an endothelial cell, and the third one
described an adipocyte. Multiple interconnections were created among these three
models in order to mimic the main physiological interactions that are known for the
examined cell phenotypes. The ultimate aim was to recreate the accomplishment of
the homeostatic balance as it was observed for an in vitro connected three-culture
system concerning glucose and lipid metabolism in the presence of the medium
flow. The whole model was based on a modular approach and on a set of nonlinear
differential equations implemented in Simulink, applying Michaelis-Menten kinetic
laws and some energy balance considerations to the studied metabolic pathways.
Our in silico model was then validated against experimental datasets coming from
literature about the cited in vitro model. The agreement between simulated and
experimental results was good and the behaviour of the connected culture system
was reproduced through an adequate parameter evaluation. The developed model
may help other researchers to investigate further about integrated metabolism and
the regulation mechanisms underlying the physiological homeostasis.
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Introduction
Over the past decades, the advent of high-throughput biotechnologies, such as
genomics and proteomics, has allowed a better understanding of the cellular and
molecular networks on which life is based. This fact, in turn, has forced a review
of the concept of a cell as a mere collection of components to be treated separately
[1]. It has become increasingly clear that signalling pathways interact with one
another and the final biological response is shaped by these interactions. The
resulting network of interactions is quite complex and may have properties that
are non-intuitive, which are often dependent on subtle timing relations and
competitions among regulators [2]. Researchers have thus moved towards an
integrative approach aiming to unveil the system properties that can emerge from
the complex interaction of basic elements [1]. Reproducing functional tissues ex
vivo, for example, requires an understanding not only of the behaviour of
individual cells, but also of how global shape and function arise from local cellular
interactions [3].
Systems biology applies quantitative, mechanistic modelling to study genetic
networks, signal transduction pathways and metabolic networks with the aim to
yield a more global, in-depth and integrated understanding of biological systems.
From a systems biology perspective, for example, all living organisms share a
notable feature, which is afforded by the interconnection and co-execution of
different functionalities: a high level of robustness against external and internal
perturbations [4].
System level understanding of complex processes is common in engineering
disciplines and relies heavily on mathematical models, informatics and methods
from systems theory. The biological field is indeed facing an increased use of
mathematical models and computer simulations; therefore, this approach is often
referred to as ‘‘in silico biology’’. The introduction of computational methods and
instruments to complement the traditional experimental ones accelerates the
generation of new hypotheses, and the research validation cycle [5]. The
mathematical modelling of complex biological systems is of iterative and
multidisciplinary kind: hypotheses emerging from in silico analyses are validated
by experimenters, and the results are used to update the computational model
exploited, thus involving various scientific fields [1].
In silico biology also offers many advantages over in vivo and in vitro
experiments: quick predictions of phenomena of interest, a great reduction of
production costs, no ethical problems (no animal needed, in line with the ‘‘3R
rule’’ [6]), user-friendly interfaces for an easy and intuitive approach, the
damping of data dispersion, which is typical of experimentally obtained
parameters, and a broad spectrum of applications (e.g., drug testing field).
Literature offers many attempts to model and simulate molecular processes,
ranging from genetic regulatory networks to metabolic pathways, and presents
several software packages, such as MIST [7], GEPASI [8], SCAMP [9], JARNAC
[10], METAMODEL [11], E-CELL SE [12], BIOSPICE [13]. Most of these
packages have been developed for the quantitative simulation of biochemical
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metabolic pathways and are based on the numerical integration of rate equations,
focusing only on metabolic aspects, without considering the environment in
which cells are immersed. Our work group, instead, has defined a different
collection of software platforms [14] [15] [16] [17] [18] with the precise purpose
to reproduce physical-chemical and intercellular interactions, to which cells living
in a physiological or an in vitro context are typically subjected, and the effects of
these stimuli on metabolism. Starting from online metabolic pathways databases,
such as the Kyoto Encyclopedia of Genes and Genomes (KEGG), and relating
them to the systems theory language, our group developed HEMETb (HEpatocyte
METabolism mathematical model b) [16], ENMET (ENdothelial METabolism
mathematical model) [17] and ADMET (ADipocyte METabolism mathematical
model) [18], three virtual cell models reproducing the hepatocyte, the endothelial
cell and the adipocyte metabolism, respectively. A subsequent model, CREPE
(mathematical model for CRoss-talking of Endothelial cells and hePatocytE
metabolism) [19], was originated through the suitable merging of HEMETb and
ENMET in order to simulate the metabolic behaviour of static hepatocyte and
endothelial cell co-cultures. The different platforms all derived from the same
previous and stoichiometric model, HEMET (HEpatocyte METabolism mathe-
matical model) [14]. All these models, implemented in Simulink (The
MathWorks, Inc.), were able to mimic the dynamic behaviour of cell
monocultures or co-cultures as a function of variations in metabolite
concentrations, using single enzymatic reactions as basic functional blocks for all
the metabolic pathways involved. The models were characterized by a modular
structure that enabled users to explore, add/subtract and modify single modules
easily, managing models through user-friendly interfaces. The Michaelis-Menten
approach in almost-steady state regime was chosen for the mathematical
modelling of enzymatic reactions, so defining basic blocks to duplicate and
connect as needed in order to form complex reaction networks as the glycolytic or
the aminoacidic ones are. However, the cited models represented only cell
monoculture metabolic profile or the behaviour of static cell co-cultures. None of
them was able to simulate the dynamic and mutual inter-change of metabolites
and the accomplishment of homeostatic balance, which are widespread
physiological phenomena. We then decided to turn attention to these noteworthy
system properties.
In vivo, many physiological and pathophysiological processes involve a great
network of signalling molecules, through which cells belonging to different tissues
can communicate and cooperate in spite of physical distance [20]. The bodily
fluids flowing through the spread vascular network are then essential for this
interaction to be possible. In metabolic regulation, for instance, liver, adipose
tissue, pancreas and muscle cooperate through several biochemical pathways
triggered by hormones and small molecules, providing the body with the right
amount of energy it needs, and storing energy substrates (i.e., homeostatic
balance) [21]. This balance is usually deranged in obese and diabetic patients or in
metabolic syndrome disease [22].
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More simple in vitro or in silico models are needed to gain insight into these
complex systems and to counteract pathological states with effective therapies. In
a simplified model of energy substrate metabolism in the visceral region, three
main tissues have to be considered as the first basic elements to reproduce:
hepatic, adipose and endothelial tissues [23]. The liver has a central role because
of its multiple anabolic and catabolic functions processing all energy substrates
(fats, sugars and proteins). Adipose tissue is not only a fat storage depot, but it is
also particularly sensitive to the overall nutritional status in the body, informing
other organs about that. Endothelial cells act as modulators of molecular
signalling: indeed, metabolites are transported along the vascular network, which
connects different organs. An in vitro model of this three-tissue system already
exists concerning the glucose and lipid metabolism, the aminoacidic degradation
and the main synthetic functions [21] [24]. It is made up of a multi-
compartmental modular bioreactor (MCmB) [26] consisting of interconnected
chambers, each one housing a specific tissue of interest. Each module can be
addressed and interrogated separately and different cell types can be added
stepwise to the system. The culture medium flow links different chambers much
as the bloodstream connects different organs in the body: this system is indeed
referred to as a ‘‘dynamic connected culture system’’. The authors of studies [21]
and [24] exploited MCmB for the reproduction of a downscaled in vitro human
visceral region to study cross-talking phenomena and their effect on metabolic
regulation. They showed this culture system to be suitable for baseline studies with
cell monocultures [23] and for upgraded analysis with cultures of two or three cell
types [21] [24]. Despite its simplicity, the overall system and monocultures were
able to reproduce several characteristics of in vivo glucose and lipid metabolism
and of homeostatic mechanisms.
In this paper, we introduce a new computational multi-scale model that merge
the previous three single-cell models (HEMETb, ENMET and ADMET) with
adequate interconnections, relating metabolic regulation to molecular biochem-
ical mechanisms. We aimed to reproduce the metabolic behaviour of three
distinct cell culture systems only connected by the medium fluid flow (dynamic 3-
way connected cell culture system): we conceived the final in silico model as a
coexistence and functional integration of the three different metabolic profiles
considered, attempting to recreate the homeostatic balance observed in vitro. At
first, each cell type was modelled as a standalone entity, with its own proliferation
rate and specific metabolic pathways. The standalone models were then
‘‘connected’’ by modelling molecular interactions among them through
metabolite uptake/release phenomena, and different kinds of cellular connections,
thus generating a 3-way (Hepatic-Endothelial-Adipose) model. Then, the model
was validated against available experimental data coming from literature datasets
about the dynamic in vitro model described above. Available data concerned only
extracellular species in the culture medium besides measurements of cell
population growth.
In Silico Models for Hepatic-Endothelial-Adipose Interaction
PLOS ONE | DOI:10.1371/journal.pone.0111946 December 15, 2014 4 / 32
Materials and Methods
1. In Silico Model Basic Structure
Our model implements metabolic networks using nonlinear differential equations
and systems theory approach, and linking biochemical pathways only to
enzymatic reactions and metabolite inter-change. The presented model was
created following the basic structure and design principles of previously developed
models like HEMETb [16], ENMET [17], ADMET [18] and CREPE [19]: they all
involved Michaelis-Menten kinetics for reversible or irreversible reactions and for
the enzymatic inhibition model, and the definition of energy constraints, such as
availability of ATP or other high-energy molecules. Cell populations were
assumed as homogeneous populations whose behaviour could thus be described
by an average cell. In particular, we used a dynamic mathematical model with
lumped parameters: the usual assumption was made that each compartment (i.e.,
the medium and the cell) was a lumped phase (i.e., concentrations are constant
throughout the compartment). Conceptually, compartments correspond to
cellular structures, such as organelles, pooled biochemical components or the cell
environment, all of which are characterized by a spatial dimension. However, the
ordinary differential equations actually represented distinct pooled concentrations
at a single point and did not describe physical dimensions and therefore cell
geometry [25]: time was the only independent variable of our system. Sidoli et al.
[25] explain that mathematical models can be classified as structured or
unstructured, segregated or unsegregated, and deterministic or stochastic. Firstly,
a structured mathematical model includes a detailed description of the
intracellular processes in either the physical or the biochemical sense, whereas
these processes are only partially considered in unstructured models. In structured
models, kinetic or stoichiometric equations are used to describe the intracellular
reactions. This kind of models provides the advantages of flexibility and detail, but
it has the drawback of obtaining data for parameter determination and model
analysis with respect to the large number of equations involved. Secondly, an
unsegregated mathematical model assumes an average cell so that the cell
population can be considered homogeneous, without taking into account the
differences conferred by the cell age, size, growth rate and metabolic state. Finally,
deterministic models assume that the cells are not subject to random variability.
Stochastic models capture cellular functions using probability distributions, thus
taking into account randomness in the process. Therefore, according to these
definitions, the mathematical model we used can be classified as structured,
unsegregated, and deterministic.
Chemical stimuli (e.g., medium culture substances and nutrient availability)
and physical ones (e.g., the presence of flow and, only for endothelial cells, a non-
zero shear-stress value) were integrated in quantitative terms to the complex
metabolic interconnected blocks chains. The modular layout, also in agreement
with the corresponding in vitro model [24], and the user-friendly interface were
conserved. Most of the involved parameters were considered time-invariant. In
the model and during the validation phase, only temporal variations were
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evaluated for the metabolite concentrations: temporal scales for the experiments
to be completed (hours and days) were much longer than typical metabolite
transport times (generally minutes) through tissues. Metabolic pathways to
implement were defined following online databases such as KEGG [27],
BRaunschweig ENzyme DAtabase (BRENDA) [28] and consolidated biochem-
istry.
As hinted before, the basic blocks derived from Michaelis-Menten kinetic
model for irreversible enzymatic reactions:
d P½ 
dt
~{
d S½ 
dt
~
Vmax S½ 
Kmz S½  ð1Þ
where P½  (mM) is the product concentration, S½  (mM) is the substrate
concentration, and Km (mM) and Vmax (mMs
21) are the Michaelis-Menten
constant and the maximum catalysis rate of enzyme, respectively.
For reversible reactions, the Michaelis-Menten equation we referred to is:
d½P
dt
~{
d½S
dt
~
Vmaxd
½S
Kmd
{Vmaxi
½P
Kmi
1z ½SKmd
z
½P
Kmi
ð2Þ
where Kmd (mM) and Kmi (mM) are the reaction Michaelis–Menten constants for
direct and inverse reaction, respectively, and Vmaxd (mMs
21) and Vmaxi (mMs
21)
are the maximum catalysis rate that can be reached in direct and inverse reaction,
respectively. IfKmi~?, i.e. product release step is irreversible, Equation (2)
becomes equal to Equation (1).
Competitive enzymatic inhibition was introduced in the model by Equation
(3):
d½P
dt
~{
d½S
dt
~
Vmax
½S
Kmd
Km 1z
I½ 
Ki
 
z S½ 
ð3Þ
where I½  (mM) represents competitive inhibitor concentration and Ki (mM) is
the inhibition constant. As in the previous case, if Ki~?, i.e. inhibitor is never
bound to enzyme, Equation (3) becomes Equation (1).
In general, metabolic pathways involve reactions with multiple substrates and/
or products and other equations have to be defined. Supposing to deal with an
nsubstrates-mproducts reaction in which all reactants are taken up at the same
instant, we can write more general equations. Therefore, equations (1) and (2)
became respectively Equation (4) and (5):
d½Pm
dt
~{
d½Sn
dt
~
VmaxPn ½Sn
KmzPn ½Sn ð4Þ
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d½Pm
dt
~{
d½Sn
dt
~
Vmax(
Pn ½Sn
Kmd
{
Pm ½Pm
Kmi
)
1zPn ½SnKmd
z
Pm ½Pm
Kmi
ð5Þ
where Km, Kmd and Kmi now are the mean of the corresponding Km, Kmd and Kmi
of each component.
In this model, the maximum rates in direct and inverse reactions are supposed
equal (in accordance with their similar order of magnitude) and these parameters
include correction factors to count other non-instantaneous processes, such as
gene expression, that slow down global processes [16]. It is noteworthy that values
for kinetic parameters, such as Km and Vmax, can be found in enzyme data bank
(BRENDA), as we will see later: inevitably, this procedure introduces some
uncertainty level in the model, due to non-standard experimental protocol and
measurement units with which values are obtained [29] [30]. For most processes,
indeed, kinetic parameters are not directly accessible in vivo and existing
biochemical data usually originate from different experimental settings, cell types
and state of cells.
In accordance with systems theory approach, it is possible to reproduce entire
metabolic pathways as series of ODEs (Ordinary Differential Equations), in which
metabolite concentrations are state variables and equations (4–5) become state
equations. Considering these equations as basic Simulink blocks, according to
block diagram algebra rules and linking these basic elements in series and/or in
parallel, we can recreate an entire pathway. Each described pathway constitutes a
block chain that can be connected to other block chains in case of shared
metabolites. The block structure is user-friendly and highly expandable. It is easy,
indeed, to define new cell types by adding or removing some blocks just as we did
in previous works, when we created ENMET [17] and ADMET [18], starting from
HEMETb. Otherwise, single virtual cell models can be merged adequately to
mimic their interaction in vivo and/or in vitro, as we did developing CREPE [19]
focusing on the effect that endothelin-1 (secreted by endothelial cells) has on the
hepatic glucokinase activity.
Here is a synthesis of the main metabolic pathways already reproduced in the
previous three different virtual cells. HEMETb model describes the hepatic cell
metabolism in standard conditions (cell culture in a plastic multi-well placed in
an incubator at 37 C˚ with 5% of CO2) and with excess substrates concentration,
hence considering cell culture proliferation, nutrient uptake glycolysis, pentose
phosphate pathway, degradation of proteins, urea production, glycogen, fatty acid
and albumin syntheses, whereas excluding the other metabolic pathways, such as
b-oxidation. ENMET mimics the same principal metabolic pathways, with the
exclusion of glycogen and albumin synthesis and the addition of shear stress
generation, nitric oxide production and endothelin-1 secretion, connecting
mechanical stimuli responses (i.e., vasoactive substances production) to other
biochemical reactions. ADMET includes the following metabolic pathways:
In Silico Models for Hepatic-Endothelial-Adipose Interaction
PLOS ONE | DOI:10.1371/journal.pone.0111946 December 15, 2014 7 / 32
glucose and aminoacid uptake, glycolysis, pentose phosphate pathway, Krebs
cycle, aminoacid degradation, fatty acid and triglyceride synthesis, lipolysis, and
the energy function. In particular, this model mimics the behaviour of a human
white fat cell that responds to various compositions of the culture medium, with
glycerol and free fatty acid release, which are the main indicators of fat cell
activity. In the present work, we focused our attention on the integration of
metabolism for the three different cell phenotypes and we dealt with these
metabolic pathways: a suitable revision of cell culture proliferation models, the
maintenance of glycemic balance, the uptake or release processes for specific
metabolites, the triglyceride/free fatty acid cycle and glyceroneogenesis. These
topics are individually discussed below. The additions regarding detailed
carbohydrate metabolism and other metabolic aspects were necessary to describe
interactions among different cell types. To take a couple of examples: we had to
implement anabolic pathways, such as gluconeogenesis, to account for a glucose
release process; similarly, we had to introduce glycerol metabolism pathway to
validate our model against experimental glycerol concentration data. Novelties
and improvements introduced with regard to the model presented are described
in details in the following sections. Fig. 1 shows the main interface of the
complete model (for further details on the state variables and the state equations
employed in our model, see S1, S2 and S3 Tables).
2. Cell Proliferation Models
In HEMET, HEMETb and ENMET cell proliferation was modelled with a logistic
function, which is characterized by the following general quadratic form:
dN(t)
dt
~C:N(t){b:N(t)2 ð6Þ
where C and b are respectively cell growth rate and death rate. In ADMET,
adipose population was considered constant over time. In CREPE, a less compact
equation (derived from Equation (6)) was implemented and its analytical
expression is reported here below with respect to endothelial cell growth:
dNET(t)
dt
~CET :NET(t)| 1{
aET :NET tð Þ
Aw
{
SC
S
:NET tð Þ
 
ð7Þ
In equation (7), the death term correlates both with contact inhibition (second
term in square brackets) and substrate lack (third term in square brackets). For
further details on the significance of each coefficient and subscript, please see ref.
[21].
In this work, we defined a cell proliferation model for each cell phenotype
considered. Available literature data were collected, looking for works with
methodological consistency in terms of cell lines and culture conditions. These
data were extracted through graphical analysis and then elaborated with Curve
Fitting Toolbox (The MathWorks, Inc.) to test hypotheses and estimate parameter
values.
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Numerical data about hepatocytes derived from the study [31], where HepG2
immortalized cell line was used as the experimental model both in static and
dynamic (i.e., with medium flowing through the bioreactor) culture conditions.
Upon validating the logistic model (Equation (6)) against these data and
estimating parameter values, we defined the final form of the logistic equation to
implement as the one published by Verhulst [32] in 1838:
dN(t)
dt
~C:N(t)| 1{
1
K
:N(t)
 
ð8Þ
where C is the proliferation rate (h21) and the negative term relating to N2 tð Þ
accounts for contact inhibition phenomena, which are typical of HepG2 cells. In
particular, K is the carrying capacity of the system. We also considered the
Fig 1. The main interface of the complete (3-way connected) model developed in this work. There are three principal blocks, represented by cell
images: from top to bottom, they correspond to networks of reactions describing endothelial, adipose and hepatic metabolism. On the right side, it is possible
to see blocks simulating extracellular fatty acid and glycerol concentrations.
doi:10.1371/journal.pone.0111946.g001
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absence of a delay term at the start of proliferation (thinking of hepatic cells as
already adapted to culture conditions) and the absence of a death term due to
substrate lack (supposing nutrients were sufficient for the short duration of the
experiments).
Estimated mean coefficient values were used for the implementation phase:
Cmean~0:034385 h
21 and Kmean~5:294:105 cells.
Data about endothelial cells proliferation came from the study [33], where
baseline experiments were conducted comparing HepG2 and endothelial
population behaviour: results showed that endothelial cell proliferation was
negligible if compared with the one of hepatocytes, other things being equal. In
addition, cultures started with settled cells and, because of the 48 h duration of the
same experimental tests, endothelial cells did not show contact inhibition
phenomena, nor underwent substrate lack [33]. Taken together, these observa-
tions led us to consider endothelial population constant over time and equal to
the number of cells initially seeded N0ð Þ.
Adipocytes were similarly treated: experiments considered in the subsequent
validation phase involved only mature adipocytes, while culture conditions and
the duration of experiments did not allow cells to differentiate, as well explained
and confirmed by cell counting tests in the work [34]. Therefore, adipose
population was considered time-invariant and equal to its initial value N0ð Þ.
For endothelial cells and adipocytes, cell proliferation model was described by
the following equation:
N tð Þ~N0 ð9Þ
Seeding values for different cell phenotypes are specified below.
These simple equations about cell proliferation may clash with the detailed
enzymatic step introduced in the model (see below), but we choose not to take
into account other aspects, e.g. turn over of different metabolites, in order to
make our final model less complex. We instead focused our modelling efforts on
metabolic pathways. Equations (8) and (9) were implemented for static as well as
for dynamic cultures, according to what stated in the work [23], which we selected
for the validation phase: Vinci et al. did not report numerical data about cell
growth, but they affirmed that cell counting tests were performed demonstrating
that the dynamic flux did not influence the examined cell proliferation processes.
3. Integrated Metabolism
The main organs taking part in energy metabolism differ in their specific enzyme
content: each one is specialized for storing, using or producing different kinds of
energy substrates such as triglycerides (TGs), proteins or glycogen. Because
glucose and fatty acids are alternative substrates, sometimes competing, many
interactions among metabolic pathways involve them [35]. This type of inter-
organ cooperation is afforded by an intense and coordinated metabolic cross-
talking.
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For example, one of the main roles of the liver is the maintenance of glycemic
levels: this organ is able to perceive a fasted state and then enhance glucose
synthesis and its exportation to other tissues. In co-cultures described in [47],
hepatocytes were shown to reduce their glucose uptake rate, in favour of glucose
dependant cell populations. As discussed later, this homeostatic behaviour was
tested in the validation phase of our workflow. Concerning lipid metabolism
instead, an enzyme with a key-role is lipoprotein lipase [48], which is localized on
the luminal surface of endothelium and is responsible for the hydrolysis of
circulating TGs, once they are released by the hepatic tissue.
3.1. Fatty Acid and Glycerol Transport Mechanisms
The transportation of molecules through the cell membrane bilayer is of
paramount importance for the organism vitality [35]. Here, we focus on two
kinds of transport proteins and on their role in homeostatic mechanisms.
The liver is one of the main regulators of metabolite flux, removing metabolites
from blood or releasing them in it. In particular, fatty acid uptake phenomena in
hepatocytes have been intensely investigated, for example [36]. Circulating free
fatty acids (FFA), coming from lipolysis of stored TGs in adipocytes and from
dietary fat, are an important source of lipids for the hepatocytes. Once in
hepatocytes, FFA may either undergo b-oxidation in mitochondria, to produce
both energy for the cell and ketone bodies, or be converted to TGs, which can be
used for the production of very low-density lipoproteins, then exported. Excess
TGs may be stored in lipid droplets.
Kinetic studies, employing almost-physiological conditions, have shown that
FFA uptake rates can best be interpreted as the combination of a saturable
component and a linear non-saturable one [37] and that the uptake rate depends
on the unbound FFA concentration. However, the values for diffusion constant
are generally very small if compared to those typical of facilitated transport
parameters, thus the contribution of diffusion to uptake rate may be reduced or
neglected in an analytical model [38]. Therefore, the total FFA uptake by
hepatocytes depends on both the concentration of FFA in plasma and the capacity
of the cells for FFA uptake. For hepatic and adipose tissues, various proteins
mediate fatty acid transport through the membrane. One of the best known is
fatty acid translocase (FAT, also referred to as CD36) [39] [40]. In physiological
concentration conditions for total plasma fatty acids (bound and unbound, 0.45
mM), saturation kinetic prevails and it is well described by a Michaelis-Menten
model equation:
d S½ 
dt
~
Vmax: S½ 
Kmz S½  ð10Þ
where S½  is the unbound FFA concentration and Vmax and Km are kinetic
parameters relating to protein mediated transport, in analogy to what seen for
enzymes.
In this work, in order to simplify fatty acid transport modelling, only a
saturable kinetic was chosen with the mediation of a single kind of protein, CD36,
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for all three cell phenotypes involved. Kinetic parameters for long-chain fatty acids
were studied for adipocytes, hepatocytes [37] and endothelial cells [41] through
[3H]-oleate uptake assays. As shown in Table 1, we used these measurements,
adequately elaborated, to implement our in silico model.
In our body, adipocytes are one of the major sources of glycerol, which is in
turn one of the main substrates of hepatic gluconeogenesis [42]. Briefly, during
fasting, energy stored as TGs in adipocytes, is made available to other tissues by
release of fatty acids, which are exported by special fatty acid transporters, and of
glycerol, which is exported through suitable porins referred to as aquaglycer-
oporins type 7 (AQP7). The preferred hepatic gluconeogenic substrate, glycerol,
directly flows in the liver via the portal vein and passes through aquaglyceroporin
type 9 (AQP9) reaching the hepatocyte cytoplasm, where it is converted into
glycerol-3-phosphate. This is in turn a substrate for gluconeogenesis or, along
with fatty acids, it is then esterified to TGs. Multiple research groups have reached
the same conclusion: these two proteins (AQP7 and AQP9) form an axis for
energy transfer characterized by a coordinated regulation [42]. Glycerol transport
through aquaglyceroporins pores is an example of facilitated diffusion and it is
driven by the concentration gradient existing between extracellular and
intracellular compartments [43]. When molecules diffusion through plasma
membrane is analysed, Fick’s law often takes on this form:
J~{P:A:DC ð11Þ
where P (cm/s) is the permeability coefficient of the membrane for a given
substance and can be experimentally defined. This coefficient includes the
diffusion coefficient D (cm2/s) and the membrane thickness Dx (cm), while A is
the membrane area and DC stands for the concentration difference. Glycerol
permeability values for cell membranes expressing AQP7 and AQP9 can be found
in literature as defined through [14C]-labelled solute assays and radioactivity
measurements. In this work, we assumed a diffusive process thoroughly mediated
by aquaglyceroporins to mimic glycerol transport in hepatic and adipose tissues.
Permeability coefficients for AQP7 [44] and AQP9 [45] [46] were calculated
starting from available glycerol uptake rate values and surface to volume ratios for
cells, as reported in Table 2.
Table 1. Fatty Acid Translocase kinetic parameters for hepatic (CD36EP), endothelial (CD36ET) and adipose (CD36AD) cells in a saturable process.
Cellular Fatty Acid
Translocase Function Km (mM) Vmax (mM h
21cell21) Reference
CD36EP Fatty acid uptake 113?10
26 8.76 [37]
CD36ET Fatty acid uptake 25?10
26 0.17 [51]
CD36AD Fatty acids uptake 101?10
26 0.0025 [37]
doi:10.1371/journal.pone.0111946.t001
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3.2. Glyceroneogenesis and the Triglyceride/Fatty Acid Cycle
During fasting in all mammals, triglyceride stored in adipose tissue is hydrolysed
by a hormone-sensitive lipase to produce free fatty acids and glycerol. Glycerol is
exported to the liver, whereas in the adipose tissue there is a considerable re-
esterification of FFA depending on intracellular glycerol-3-phosphate concentra-
tion. The triglyceride/fatty acid cycle includes local intracellular recycling, within
the adipose tissue, and extracellular or systemic recycling, through the formation
of TGs in the liver. Intracellular recycling appears to represent almost 20–30% of
the total, whereas non-adipose tissue recycling (primarily hepatic) accounts for
50% of re-esterification of fatty acids in healthy adults after an overnight fast [49].
It is clear that this cycle requires the constant generation of glycerol-3-phosphate
for triglyceride synthesis.
The liver can readily use the glycerol as a source of glycerol-3-phosphate thanks
to a considerable glycerol kinase activity. In adipose tissue, instead, there is a
special pathway for the generation of glycerol-3-phosphate from precursors other
than glucose: it is termed glyceroneogenesis and it is an abbreviated version of
gluconeogenesis. Indeed, the tissue contains both pyruvate carboxylase and the
cytosolic form of phosphoenolpyruvate carboxykinase. Therefore, any variation in
adipocyte glucose uptake and in glyceroneogenesis flux, notably affects
triglyceride/fatty acid cycle in these cells [49].
4. New and Specific Metabolic Pathways Introduced
4.1. Hepatic Pathways
In order to reproduce hepatic cell behaviour with regard to metabolic
homeostasis, we introduced the following aspects in the model: gluconeogenesis,
glycogenolysis, glycerol metabolism, FFA and TG syntheses, glucose uptake and
release, fatty acid uptake, triglyceride release and glycerol uptake.
Gluconeogenesis is the generation of glucose from non-carbohydrate carbon
substrates such as pyruvate. In this work, only two substrates of that kind were
considered: aminoacids and adipose glycerol. This way proceeds in opposite
direction with respect to glycolysis and three specific enzymes counteract
glycolytic irreversible kinetic steps, whereas the other seven gluconeogenic
reactions are catalysed by the remaining glycolytic enzymes. The gluconeogenic
enzymes introduced are pyruvate carboxylase (PYC, 6.4.1.1, irreversible),
phosphoenolpyruvate carboxykinase (PEPCK-C, 4.1.1.32, reversible) and fruc-
tose-1,6-bisphosphatase (FBPase, 3.1.3.11, irreversible).
Table 2. Aquaglyceroporin permeability values for hepatic (AQP9) and adipose (AQP7) glycerol transport.
Aquaglyceroporins Function Pglycerol (m h
21) Reference
AQP9 Glycerol uptake 0.396?1023 [46]
AQP7 Glycerol release 0.09?1023 [44]
doi:10.1371/journal.pone.0111946.t002
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Glycogenolysis involves mobilization and degradation of glycogen stores to
produce directly available energy substrates and implies the breakage of a 1?4ð Þ
and a 1?6ð Þ bounds. The new enzymes are glycogen phosphorilase (GPase,
2.4.1.1, reversible, in vitro) and a-1,6-glycosidase (A16G, 3.2.1.33, irreversible).
The result is the production of glucose and glucose-6-phosphate.
As discussed above, glycerol uptake was modelled through the first Fick’s law as
a pore mediated (AQP9) diffusive process. Once in the hepatocyte, glycerol can
become a gluconeogenic substrate through the combined action of glycerol kinase
(GroK, 2.7.1.30, irreversible) and of phosphate glycerol dehydrogenase (G3PDH,
1.1.1.8, reversible). The ATP-dependent phosphorilation catalyzed by glycerol
kinase gives glycerol-3-phosphate, which can also become a substrate for TG
synthesis.
Fatty acid transport instead was treated with a saturation kinetic through
transmembrane protein CD36. FFA and TG syntheses were then modelled
following the kinetic approach reported in [18]. TGs were supposed to directly
pass through the cell membrane and reach the extracellular compartment. For
glucose, a bidirectional movement and a proportional term of release/uptake was
implemented with regard to intracellular/extracellular glucose concentration,
respectively.
The hepatic metabolic pathways implemented are summarized in Fig. 2.
4.2. Endothelial Pathways
In order to reproduce endothelial cell behaviour with regard to metabolic
homeostasis, we considered the following metabolic pathways: gluconeogenesis,
FFA and TG syntheses, lipolytic action of lipoprotein lipase, glucose uptake and
release, fatty acid uptake.
On the inner surface of capillaries, circulating TGs can be hydrolyzed to form
glycerol and FFA thanks to the action of the extracellular enzyme lipoprotein
lipase (LPL, 3.1.1.34, irreversible). The neighbouring cells can reabsorb energy
products. This metabolic aspect is involved only in the 3-way connection scheme,
where hepatic TGs act as enzymatic substrate. In regards to fatty acid release, we
referred to data reported in study [51]. We supposed that only 40% of available
TGs was converted into FFA and 3 nmol of the latters were obtained from each
nanomole of TGs.
All the other pathways were implemented as described above for the
hepatocyte. The endothelial cell metabolism implemented is summarized in
Fig. 3.
4.3. Adipose Pathways
In order to reproduce adipocyte behaviour with regard to metabolic homeostasis,
we dealt with the subsequent pathways: glyceroneogenesis, glucose uptake and
release, fatty acid uptake and release, intracellular re-esterification of fatty acids,
glycerol release.
For the glyceroneogenesis, we exploited enzymatic blocks already implemented
in the available adipocyte model: pyruvate carboxilase, phosphoenolpyruvate
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carboxykinase (now reversible), and glycerol-3-phosphate dehydrogenase. The
adipose intracellular component of the previously described triglyceride/fatty acid
cycle accounts for about 25% of the re-esterification of the total TGs produced by
the cells themselves. As done for the hepatocyte, glycerol release was modelled as a
pore mediated (AQP7) diffusive process for glycerol coming from TG hydrolysis.
The whole adipocyte metabolism implemented is summarized in Fig. 4.
Fig 2. Block diagram showing an overall view of the metabolic pathways with respective interconnections implemented for hepatic cell. High-
energy molecules (ATP, NADH, etc.) metabolism and energy function are not included for clarity, because they influence every subsystem.
doi:10.1371/journal.pone.0111946.g002
Fig. 3. Block diagram showing an overall view of the metabolic pathways with respective interconnections implemented for endothelial cell. The
model of the shear-stress acting on the cell is also reported.
doi:10.1371/journal.pone.0111946.g003
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4.4. Selected Simulations and Metabolite Concentrations in the Culture Medium
As we will see later, a key point of the validation phase is the comparison between
simulated metabolite concentrations and the measured ones for glucose, fatty
acids and glycerol. For each metabolite in the culture medium, a corresponding
extracellular integrator was implemented in the model. Initial condition values
were specified basing upon available experimental data [23] [24].
At first, in this work, single-cell simulations were compared with baseline
monoculture experiments focusing on static conditions. Then, two kinds of
configuration were studied to investigate about the metabolic homeostasis of the
same in vitro cell systems in dynamic conditions: single-cell simulations, which
were compared with baseline monoculture studies carried out in the presence of
the medium flow, and simulations for a three-cell in silico model, which were
compared with results from the 3-way connected culture system, were examined.
As the configuration changed, from single-cell model to three-cell model, so did
state equations for metabolites of interest (i.e., cell specific terms were added or
deleted from the equations). Extracellular metabolite concentrations for the 3-way
connected system were described through the following three state equations:
d GluEX½ 
dt
~{CETgNET GluEX½ zRETgNET GluET½ 
{CADgNAD GluEX½ zRADgNAD GluAD½ 
{CEPgNEP GluEX½ zREPgNEP GluEP½ 
ð12Þ
d FAEX½ 
dt
~{CD36ET :NETz0,40:3:TGET :NET
{CD36AD:NADz3:HSL: 1{0:25ð Þ
{CD36EP:NEPzLPL:NEP
ð13Þ
Fig. 4. Block diagram showing an overall view of the metabolic pathways with respective interconnections implemented for adipose cell.
doi:10.1371/journal.pone.0111946.g004
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d GroEX½ 
dt
~zAQP7:NAD{AQP9:NEP ð14Þ
where GluEX½ , FAEX½  and GroEX½  are extracellular glucose, fatty acid and
glycerol concentrations respectively, GluET½ , GluAD½  and GluEP½  are instead
intracellular glucose concentrations, NET½ , NAD½ and NEP½  are the number of cells
for the three phenotypes considered, Cs and Rs are cellular glucose uptake and
release rates, respectively; the other terms are enzymatic rates for corresponding
enzymes or transport proteins. Equations (12), (13) and (14) inevitably consisted
of many terms: in order to reproduce metabolic interactions among different cell
types, we had to consider uptake and release phenomena for mutually inter-
changed metabolites. Those equations allowed us to correlate measured
extracellular metabolite concentrations with metabolic processes occurring inside
the cells. The same equations were exactly used for all of our simulations
concerning the 3-way connected system. For the sake of simplicity, equations are
reported in the text only for the complete model. Simpler equations were
implemented for single-cell simulations (for details, see S2 Table). All the values
used for new kinetic enzyme parameters are listed in Table 3 and Table 4.
5. Validation Procedure
The validation phase was based upon three studies [21] [23] [24], characterized by
a logical and temporal order. The same group of authors conceived them to
analyse metabolic homeostasis in the human visceral region.
The duration of all their experiments was equal to 48 h, so we assumed that one
simulation time unit was equivalent to 4 h and each simulation lasted 12 time
units. We used ode 23 s (stiff/Mod.Rosenbrock) as numerical integration method.
The cell simulators did not take into account any change of the culture medium.
Extracellular concentration data were available from the three works for four
different sampling times (0, 15, 24 and 48 h) and for glucose, fatty acid and
glycerol concentrations. We extracted their numerical values exploiting tables or
graphical analysis of plots reported. Extracted values were expressed as means with
respective standard deviation and they were often affected by an unmodifiable
large deviation [23] [24], as we will see below. In order to analyse the differences
between the dynamic and static monocultures, the authors of study [23] chose to
focus on the net change of metabolite concentrations in the culture medium
between 0 and 48 h, as after this time cells were thought to be adapted to seeding
and culture conditions. We adopted the same approach for the comparison
between simulation and experimental data, focusing on the first and the last data
points. As for glucose and aminoacid concentrations (input variable), we decided
to use the known Eagle’s MEM formulation values, as reported in Table 5.
Currently, as for intracellular metabolite concentration, quantitation of all the
metabolites in a cellular system in a given state at a given point in time is
impossible, because of the lack of simple automated analytical strategies that can
In Silico Models for Hepatic-Endothelial-Adipose Interaction
PLOS ONE | DOI:10.1371/journal.pone.0111946 December 15, 2014 17 / 32
T
a
b
le
3
.
E
n
zy
m
a
tic
p
a
ra
m
e
te
rs
(K
m
fo
r
d
ir
e
ct
K
m
d
ð
Þa
n
d
in
d
ir
e
ct
K
m
i
ð
Þre
a
ct
io
n
s,
V
m
ax
,
ki
n
e
tic
ra
te
e
xp
re
ss
io
n
s)
re
la
tin
g
to
th
e
n
e
w
e
n
zy
m
e
s
in
tr
o
d
u
ce
d
in
th
e
m
o
d
e
lf
o
r
ca
rb
o
h
yd
ra
te
m
e
ta
b
o
lis
m
.
E
n
zy
m
e
E
C
n
u
m
b
e
r
V
m
ax
(m
M
h
2
1
)
K
m
d
(m
M
)
K
m
i
(m
M
)
K
in
e
ti
c
ra
te
P
yr
u
va
te
ca
rb
o
xy
la
se
6
.4
.1
.1
2
6
3
1
6
0
0
.2
4
(p
yr
u
va
te
/A
T
P
1
)
PY
C
~
V
m
ax
PY
C
Py
ru
v
½
A
T
P
½

K
m
PY
C
z
Py
ru
v
½
A
T
P
½

P
h
o
sp
h
o
e
n
o
l-
p
yr
u
va
te
ca
rb
o
xy
ki
-
n
a
se
4
.1
.1
.3
2
D
ir
e
ct
:
6
8
.0
5
8
In
d
ir
e
ct
:
5
7
.1
1
4
0
.0
2
6
(o
xa
la
ce
ta
te
)
0
.0
4
8
(P
E
P
)
PE
PC
K
{
C
~
V
m
ax
PE
PC
K
{
C
O
xa
la
ce
ta
te
½
A
T
P
½

K
m
PE
PC
K
{
C
D
{
PE
P
½

K
m
PE
PC
K
{
C
I


1z
O
xa
la
ce
ta
te
½
A
T
P
½

K
m
PE
PC
K
{
C
D
z
PE
P
½

K
m
PE
PC
K
{
C
I


.
F
ru
ct
o
se
-1
,6
-b
is
p
h
o
sp
h
a
ta
se
3
.1
.3
.1
1
1
3
9
.0
9
2
0
.0
0
1
6
(F
B
P
)
FB
Pa
se
~
V
m
ax
FB
Pa
se
FB
P
½

K
m
FB
Pa
se
z
FB
P
½

G
lu
co
se
-6
-p
h
o
sp
h
a
ta
se
3
.1
.3
.9
4
8
0
0
?1
0
-9
4
.8
(G
6
P
)
4
(G
lu
co
se
)
(s
u
p
p
o
se
d
va
lu
e
)
G
6P
{
C
~
V
m
ax
G
6P
{
C
G
6P
½

K
m
G
6P
{
C
D
{
G
lu
½

K
m
G
6P
{
C
I


1z
G
6P
½

K
m
G
6P
{
C
D
z
G
lu
½

K
m
G
6P
{
C
I


G
ly
co
g
e
n
p
h
o
sp
h
o
ry
la
se
2
.4
.1
.1
2
0
1
6
1
.4
(G
ly
co
g
e
n
)
1
.3
(G
1
P
)
G
Pa
se
~
V
m
ax
G
Pa
se
G
ly
co
ge
n
½

K
m
G
Pa
se
D
{
G
1P
½

K
m
G
Pa
se
I


1z
G
ly
co
ge
n
½

K
m
G
Pa
se
D
z
G
1P
½

K
m
G
Pa
se
I


A
lp
h
a
-1
,6
-g
lu
co
si
d
a
se
3
.2
.1
.3
3
6
6
0
0
.0
6
3
(G
ly
co
g
e
n
)
A
16
G
~
V
m
ax
A
16
G
G
ly
co
ge
n
½

K
m
A
16
G
z
G
ly
co
ge
n
½

1
A
b
b
re
vi
a
tio
n
s:
A
T
P
(A
d
e
n
o
si
n
e
T
ri
P
h
o
sp
h
a
te
);
P
yr
u
v
(P
yr
u
va
te
);
P
E
P
(P
h
o
sp
h
o
E
n
o
lP
yr
u
va
te
);
F
B
P
(F
ru
ct
o
se
-B
is
P
h
o
sp
h
a
te
);
G
6
P
(G
lu
co
se
-6
-P
h
o
sp
h
a
te
);
G
lu
(G
lu
co
se
);
G
1
P
(G
lu
co
se
-1
-P
h
o
sp
h
a
te
).
do
i:1
0.
13
71
/jo
ur
na
l.p
on
e.
01
11
94
6.
t0
03
In Silico Models for Hepatic-Endothelial-Adipose Interaction
PLOS ONE | DOI:10.1371/journal.pone.0111946 December 15, 2014 18 / 32
T
a
b
le
4
.
E
n
zy
m
a
tic
p
a
ra
m
e
te
rs
(K
m
fo
r
d
ir
e
ct
K
m
d
a
n
d
in
d
ire
ct
K
m
i
re
a
ct
io
n
s,
V
m
ax
,
ki
n
e
tic
ra
te
e
xp
re
ss
io
n
s)
re
la
tin
g
to
th
e
n
e
w
e
n
zy
m
e
s
in
tr
o
d
u
ce
d
in
th
e
m
o
d
e
lf
o
r
lip
id
m
e
ta
b
o
lis
m
.
E
n
zy
m
e
E
C
n
u
m
b
e
r
V
m
ax
(m
M
h
2
1
)
K
m
d
(m
M
)
K
m
i
(m
M
)
K
in
e
ti
c
ra
te
A
ce
ty
l-C
o
A
ca
rb
o
xy
la
se
6
.4
.1
.2
3
7
2
3
0
.0
5
(A
ce
ty
l-
C
o
A
1
)
A
C
C
~
V
m
ax
A
C
C
A
ce
ty
lC
oA
½
A
T
P
½

K
m
A
C
C
z
A
ce
ty
lC
oA
½
A
T
P
½

F
a
tt
y-
a
ci
d
sy
n
th
a
se
2
.3
.1
.8
5
1
9
2
1
2
?1
0
-6
0
.0
1
9
(M
a
lo
n
yl
-C
o
A
)
FA
S~
V
m
ax
FA
S
M
al
on
yl
C
oA
½
N
A
D
PH
½

K
m
FA
S
z
M
al
on
yl
C
oA
½
N
A
D
PH
½

G
ly
ce
ro
l
ki
n
a
se
2
.7
.1
.3
0
7
6
2
?1
0
2
3
0
.0
4
6
(G
ly
ce
ro
l)
G
ro
K
~
V
m
ax
G
ro
K
G
ly
ce
ro
l
½
A
T
P
½

K
m
G
ro
K
z
G
ly
ce
ro
l
½
A
T
P
½

G
ly
ce
ro
l-
3
-p
h
o
sp
h
a
te
d
e
h
yd
ro
g
e
n
a
se
1
.1
.1
.8
3
5
7
0
0
0
0
.1
5
(D
H
A
P
)
0
.0
1
(N
A
D
H
)
0
.1
9
(G
ly
ce
ro
l-
3
P
)
G
3P
D
H
~
V
m
ax
G
3P
D
H
D
H
A
P
½
N
A
D
H
½

K
m
G
3P
D
H
D
{
G
ly
ce
ro
l3
P
½

K
m
G
3P
D
H
I


1z
D
H
A
P
½
N
A
D
H
½

K
m
G
3P
D
H
D
z
G
ly
ce
ro
l3
P
½

K
m
G
3P
D
H
I


A
cy
l-
C
o
A
S
yn
th
a
se
6
.2
.1
.3
1
0
7
.1
7
5
?1
0
2
3
0
.0
0
2
7
8
(P
a
lm
yt
a
te
)
A
C
A
S~
V
m
ax
A
C
A
S
FA
EP
½
A
T
P
½

K
m
A
C
A
S
z
FA
EP
½
 A
T
P
½

G
ly
ce
ro
l-
3
-p
h
o
sp
h
a
te
a
cy
ltr
a
n
sf
e
ra
se
2
.3
.1
.1
5
3
.8
7
6
0
.4
6
(G
ly
ce
ro
l-
3
P
)
0
.0
0
3
1
(P
a
lm
ito
yl
-C
o
A
)
1
-a
cy
lg
ly
ce
ro
l-3
-p
h
o
sp
h
a
te
a
cy
ltr
a
n
sf
e
ra
se
2
.3
.1
.5
1
1
0
.9
8
?1
0
2
6
0
.0
1
6
3
0
(A
cy
l-
C
o
A
)
D
ia
cy
lg
ly
ce
ro
l
a
cy
ltr
a
n
sf
e
ra
se
2
.3
.1
.2
0
6
7
2
3
?1
0
2
3
0
.0
0
8
(O
le
o
yl
-C
o
A
)
S
T
G
(S
yn
th
e
si
s
o
f
T
ri
g
ly
ce
rid
e
s)
(c
u
m
u
la
tiv
e
)
ST
G
~
V
m
ax
ST
G
A
C
oA
½
G
ly
ce
ro
l3
P
½

K
m
ST
G
z
A
C
oA
½
G
ly
ce
ro
l3
P
½

L
ip
o
p
ro
te
in
lip
a
se
3
.1
.1
.3
4
2
.2
6
1
0
.0
5
3
(V
L
D
L
)
LP
L~
V
m
ax
LP
L
T
ri
cl
yc
er
id
e E
P
½

K
m
LP
L
z
T
ri
gl
yc
er
id
e E
P
½

1
A
b
b
re
vi
a
tio
n
s:
A
T
P
(A
d
e
n
o
si
n
e
T
ri
P
h
o
sp
h
a
te
);
D
H
A
P
(d
ih
yd
ro
xy
a
ce
to
n
e
p
h
o
sp
h
a
te
);
N
A
D
H
(N
ic
o
tin
a
m
id
e
A
d
e
n
in
e
D
in
u
cl
e
o
tid
e
H
yd
ro
g
e
n
);
G
ly
ce
ro
l-
3
P
(G
ly
ce
ro
l-
3
-P
h
o
sp
h
a
te
);
F
A
E
P
(h
E
P
p
a
tic
F
a
tt
y
A
ci
d
s)
;
V
L
D
L
(V
e
ry
L
o
w
-D
e
n
si
ty
L
ip
o
p
ro
te
in
);
T
ri
g
ly
ce
ri
d
e
E
P
(h
E
P
p
a
tic
T
ri
g
ly
ce
ri
d
e
).
do
i:1
0.
13
71
/jo
ur
na
l.p
on
e.
01
11
94
6.
t0
04
In Silico Models for Hepatic-Endothelial-Adipose Interaction
PLOS ONE | DOI:10.1371/journal.pone.0111946 December 15, 2014 19 / 32
effect this in a reproducible and robust way. The main challenges are the chemical
complexity and heterogeneity of metabolites, the dynamic range of the measuring
technique, the throughput of the measurements, and the extraction protocols
[50]. Using mass spectrometry, comprehensive surveys of cell metabolite
concentrations have been made, but they are available only for Escherichia coli and
Saccharomyces cerevisiae. In our model, intracellular metabolite concentrations
were modelled through corresponding integrator blocks: given the lack of precise
data, we hypothesised that cells were empty at the beginning of the simulations
and we therefore set the initial condition value to zero for each intracellular
integrator.
Results and Discussion
1. Identification of Correction Factors and Validation for Cell
Monocultures
First of all, we validated single-cell models against data from baseline studies [23],
in which the effect of the medium flow on metabolic behaviour was evaluated,
thus distinguishing static and dynamic conditions. During baseline experiments
[23], 250N103 hepatocytes and 200 mg of adipose tissue (about 300N103 cells) were
Table 5. Data about glucose and aminoacid concentration values employed in the presented in silico model. They refer to Eagle’s MEM culture medium
formulation.
Chemical component Concentration [mM]
L-Alanine 0.281
L-Arginine 0.723
L-Asparagine 0.605
L-Aspartate 0.990
L-Cysteine 0.620
L-Glutamate 0.510
L-Glutamine 0.007
L-Glycine 0.666
L-Histidine 0.271
L-Isoleucine 0.396
L-Leucine 0.396
L-Lysine 0.496
L-Methionine 0.101
L-Phenilalanine 0.194
L-Proline 0.347
L-Serine 0.238
L-Threonine 0.403
L-Tryptophan 0.049
L-Tyrosine 0.286
L-Valine 0.393
D-Glucose 5.551
doi:10.1371/journal.pone.0111946.t005
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cultivated in static wells or inserted in modular bioreactor chambers (MCmB 2.0)
with extremely low shear stress for cell cultures. 80N103 endothelial cells were
seeded in static conditions or transferred to a laminar flow chamber for dynamic
tests.
Proliferation data were not available from the same work for a comparison with
simulated data. We implemented the proliferation models discussed above. Then,
according to what is affirmed in [23], where flow is said not to influence
mitogenesis, we assumed cell growth simulation results to be valid for both the
conditions examined. Fig. 5 shows different cell growth profiles, which
characterize our in silico models.
As far as metabolic profiles are concerned, a new pop-up variable to select was
introduced in silico aiming to reproduce the difference between the presence
(dynamic conditions) and absence (static conditions) of the culture medium flow
(S1(A) and S1(B) Figures). For each case tested, a different set of initialization
values was associated to that variable: the sets consisted of heuristically estimated
correction factors that were applied to enzyme kinetic parameters (S1(C) Figure).
The function of the correction factors was to modify selectively kinetic parameters
according to different culture conditions and to reproduce the main features of
metabolic profiles experimentally observed. The identification of correction
Fig. 5. The simulated cell growth profiles in function of time. These profiles result from the implementation
of the proliferation models discussed in the text. Solid line, dash-dotted line and dashed line represent
hepatocyte number, endothelial cell number and adipocyte number, respectively.
doi:10.1371/journal.pone.0111946.g005
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factors to apply allowed us to make hypotheses about the differential activation of
metabolic pathways in the culture conditions considered.
1.1. Hepatocyte Monoculture
For hepatocyte monocultures, we obtained a general and good agreement between
experimental and simulated behaviours in the static as well in the dynamic
situation and Fig. 6(A), 6(B), 6(C) and 6(D) show that. With regard to glucose
concentration, no net change was experimentally observed in static conditions,
but there was a significant cellular glucose uptake in the presence of flow [23]: we
modelled this difference through an over-regulation of glucose uptake rate in the
dynamic case. During the experiments, fatty acid uptake was present in both
conditions with a complete removal over time, which was more rapid in the
dynamic setup [23]. In silico, we obtained the same behaviour through an
Fig. 6. Measured [23] and simulated glucose and fatty acid trends in the culture medium for hepatic monocultures. Upper figures refer to static
conditions, the other ones describe dynamic conditions. Solid lines represent the simulated data, while circles (for the static case) and squares (for the
dynamic case) represent the corresponding experimental data. Measured values are expressed as means¡ standard deviation for experiments run at least
in triplicate: numerical values are reported in [23] and error bars represent the standard deviation. (A) Glucose trend in static conditions. (B) Fatty acid trend
in static conditions. (C) Glucose trend in dynamic conditions. (D) Fatty acid trend in dynamic conditions.
doi:10.1371/journal.pone.0111946.g006
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adequate regulation of kinetic parameters for both glucose and fatty acid uptake
processes. In vitro, hepatocytes showed glycerol uptake over time, principally in
dynamic conditions [23]: as suggested by the authors of the experimental study,
aquaglyceroporins probably play a key-role in this uptake process. We indeed
concentrated on the implementation of AQP9 and the regulation of its kinetic
parameters, so obtaining fair results (S2(A) and S2(B) Figures).
1.2. Endothelial Cell Monoculture
The endothelial cell simulator included shear stress parameters in dynamic
conditions. As far as glucose and fatty acid metabolism was concerned, the model
was able to reproduce the mean experimental behaviour observed [23], only in
static conditions, as shown in Fig. 7(A) and 7(B). It was more difficult to mimic
glucose uptake and fatty acid release in dynamic conditions, probably because of
Fig. 7. Measured [23] and simulated glucose and fatty acid trends in the culture medium for endothelial monocultures. Upper figures refer to static
conditions, the other ones describe dynamic conditions. Solid lines represent the simulated data, while circles (for the static case) and squares (for the
dynamic case) represent the corresponding experimental data. Measured values are expressed as means¡ standard deviation for experiments run at least
in triplicate: numerical values are reported in [23] and error bars represent the standard deviation. (A) Glucose trend in static conditions. (B) Fatty acid trend
in static conditions. (C) Glucose trend in dynamic conditions. (D) Fatty acid trend in dynamic conditions.
doi:10.1371/journal.pone.0111946.g007
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our hypothesis that cell proliferation was absent. There was only a reproduction of
the general trend of the behaviour described in [23] (Fig. 7(C) and 7(D)). Fatty
acid synthesis, uptake and consumption were indeed implemented, but we had to
define the intensity of these processes under precautionary assumptions in
consequence of the uncertainty of the available literature data [51]. Besides this,
the zero initial condition for intracellular fatty acid integrator did not allow the
cell to release a metabolite without having it right inside before. Glycerol
concentration profiles were neglected because in study [23] they were not
considered significant for the energy metabolism of endothelial cell, but only for
the cell permeability status.
Fig. 8. Measured [23] and simulated glucose and fatty acid trends in the culture medium for adipose monocultures. Upper figures refer to static
conditions, the other ones describe dynamic conditions. Solid lines represent the simulated data, while circles (for the static case) and squares (for the
dynamic case) represent the corresponding experimental data. Measured values are expressed as means¡ standard deviation for experiments run at least
in triplicate: numerical values are reported in [23] and error bars represent the standard deviation. (A) Glucose trend in static conditions. (B) Fatty acid trend
in static conditions. (C) Glucose trend in dynamic conditions. (D) Fatty acid trend in dynamic conditions.
doi:10.1371/journal.pone.0111946.g008
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1.3. Adipocyte Monoculture
For adipocytes, the simulation results had a fair agreement with experimental
data, principally in dynamic conditions. In the adipocyte culture, glucose
concentration was stable in static conditions whereas there was a net glucose
uptake in the dynamic ones, probably due to the effect of the culture medium flow
[23]. In silico, we indeed regulated glucose metabolism parameters. Fatty acid
release was present in both static and dynamic experimental conditions [23] and
our model was able to reproduce it, through a distributed regulation of key-
enzymes for glucose and lipid metabolism (Fig. 8(A), 8(B), 8(C) and 8(D)).
Glycerol was also released in the culture medium both in static and dynamic
conditions, as a probable consequence of constitutive lipolysis phenomena [23].
Our simulator was able to mimic the general trend, but not the intensity of the
metabolite release (S3(A) and S3(B) Figures). Once again, the implementation of
aquaglyceroporin-mediated glycerol transport improved the results. It was not
possible to enhance glycerol release further due to the general consistency of the
model. As already seen for endothelial cells, zero initial condition for intracellular
glycerol integrator was a drawback for the model itself.
2. Validation for the 3-Way Connected System: Not just a Sum
The in silico model was subsequently validated involving the examined three cell
phenotypes at the same time. We referred to experimental data reported in [21]
and [24] for a 3-way connected in vitro culture system aiming to reproduce the
metabolic homeostasis of the visceral region. This system involved hepatocytes,
endothelial cells and adipocytes: 250?103 hepatocytes and 50?103 adipocytes were
inserted in modular bioreactor chambers (MCmB 2.0) with extremely low shear
stress for cell cultures, whereas 25?103 endothelial cells were transferred to a
laminar flow chamber for dynamic tests. The chambers were connected together
through the culture medium flow.
At first, in the three-cell in silico model, we set the values of enzymatic
parameters at the same values used for monoculture simulations in dynamic
conditions, even if a small reduction of fatty acid metabolism for adipocytes was
necessary in order to maintain the consistency of the model.
Experimental data showed the presence of a homeostatic regulation mechan-
ism: changes in glucose concentration were negligible, with hepatic tissue
preserving normal glucose levels [24]. Probably, hepatic gluconeogenic produc-
tion of the metabolite compensated for endothelial and adipose glucose uptake:
intercellular cross-talking was fundamental for this kind of metabolic control to
realize. A similar experimental homeostatic balance was observed for medium
fatty acid concentration with negligible changes over time [24]: the presence of the
hepatic cell line prevented it from rising, probably through the removing action
seen in monoculture test. Experimental glycerol concentration did not show
significant variations, consistently with fatty acid trend. The presence of
hepatocytes maintained glycerol balance and the authors [24] assumed a mutual
metabolite inter-change among cell types as the possible explanation.
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Corresponding simulation results differed from experimental observations,
showing only a cumulative glucose uptake with respect to dynamic monocultures,
a complete removal of free fatty acids in the medium in contrast to a small release
from endothelial and adipose cultures, and a net glycerol decrease in the medium
as it is typical of the hepatic population. It was evident that the hepatic population
played a leading role in the shaping of the overall metabolic profile. Moreover, the
zero-initial conditions for intracellular integrators had a large effect on it
(Fig. 9(A), 9(B) and (C)).
Ultimately, the in silico model for the 3-way connected system was not able to
reproduce the metabolic behaviour and homeostatic regulation observed in vitro,
neither for the trends nor for the degree of variations in metabolite temporal
profiles. This was explained looking at enzymatic parameters. In vitro, there was
an evident adaptation of the metabolic balance to fluid dynamic conditions and
nutrient availability, through a differentiated activation of specific metabolic
Fig. 9. Measured [24] and simulated metabolite trends in the culture medium for the 3-way connected system (dynamic conditions). Solid lines
represent the simulated data, while squares represent the corresponding experimental data. Measured values are expressed as means ¡ standard
deviation: numerical values were extracted from plots reported in [24] and error bars represent the standard deviation. From three to six replicates were run
for each experiment. (A) Glucose trend in culture medium. (B) Fatty acid trend in culture medium. (C) Glycerol trend in culture medium.
doi:10.1371/journal.pone.0111946.g009
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Table 6. Parameter values employed in the two different models of the simulated 3-way connected culture system described in the text.
Description of the parameter
Simulated 3-way connected system deriving from
monoculture models
Modified simulated 3-way connected
system
Hepatic glucose uptake rate 4.784?1028 h21 cell-1 4.784?10210 h21 cell21
Vmax for hepatic fatty acid transporter CD36 8.755 mM h
21 cell21 1.751 mM h21 cell21
Hepatic membrane permeability to glycerol 3.960?1024 m h21 cell21 3.960?1027 m h21 cell21
Vmax for adipose fatty acid transporter CD36 2.5?10
23 mM h21 cell21 2.5?1024 mM h21 cell21
doi:10.1371/journal.pone.0111946.t006
Fig. 10. Measured [24] and simulated metabolite trends in the culture medium for the in-silico modified 3-way connected system. Parameter
modifications described in the text were applied to the initial 3-way connected system model. Solid lines represent the simulated data for the modified model,
dotted lines refer to the simulated data for the original in silico model (see Figure 9 for details), while squares represent the corresponding experimental
data. Measured values are expressed as means¡ standard deviation: numerical values were extracted from plots reported in [24] and error bars represent
the standard deviation. From three to six replicates were run for each experiment. (A) Glucose trend in culture medium. (B) Fatty acid trend in culture
medium. (C) Glycerol trend in culture medium.
doi:10.1371/journal.pone.0111946.g010
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pathways. The same mechanisms could not take place in silico: the values of the
kinetic parameters were fixed at the beginning of simulations and metabolite
concentrations alone were not sufficient to direct homeostatic regulation.
Running different simulations has highlighted the key-role of gluconeogenesis and
glyceroneogenesis enzymatic parameters with regard to fatty acid biosynthesis.
This is in agreement with the physiological ‘‘de novo’’ lipogenesis, which is the
synthesis of fatty acid molecules from non-lipid substrates, mainly carbohydrates.
3. Modifications for the Simulated 3-way Connected System
The simulation results described above would seem to indicate and reaffirm that
the experimental 3-way connected system is not just a sum of the three distinct
monocultures involved, but it is a complex system with ‘‘emergent properties’’
whose origin has to be identified. Equations (12), (13) and (14) seemed not to be
sufficient for the intended modelling if the same enzymatic parameters, used for
the single-cell simulators, were employed. Thus, we tried to modify some key-
parameter seeking for a more effective validation of the in silico model. An
attempt was made, basing on the biochemical and model knowledges acquired.
We thought that hepatic predominance was too strong in the 3-way connected in
silico model and we tried to reduce its contribution, modifying only few
parameters. We lowered hepatic glucose, fatty acid and glycerol uptake rates to
enhance nutrient availability for the other cell types. Referring to [47] we assumed
that, in normoglycemic conditions, hepatic tissue could lower its glucose uptake
rate to pander to cell populations that preferred glucose as energy substrate. A
comparison of the parameters values employed in the two different models of the
simulated 3-way connected system is reported in Table 6. The implementation of
the modified model produced better results, as shown in Fig. 10(A), 10(B) and
10(C). Simulated data agreed well with experimental ones, especially for glucose
and fatty acid concentrations. Glycerol profile was affected by the scarce release
from endothelial and adipose cells.
We believe that these results show that, with few variations, the implemented
model is able to reproduce the metabolic homeostasis characterizing the human
visceral compartment. In general, results were better in the case of glucose and
lipid metabolism than in that of glycerol one. Future developments of the model
may be able to investigate the significance of these modifications with more
accuracy.
Conclusions
Many key organs exploit complex molecular signalling pathways and interact each
other to maintain the systemic energy balance of a living organism. This balance is
usually deranged in obese and diabetic patients or in the metabolic syndrome
disease. Clearly, the availability of tools to better understand the metabolic cross-
talking phenomena is essential for finding the most appropriate interventions to
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treat or prevent meatabolic diseases. We have presented a new computational
modular model, which is able to reproduce the metabolic behaviour observed for
connected culture systems in dynamic conditions. We have studied integrated
metabolism and tried to explain possible regulation mechanisms and emergent
properties coming from the combination of distinct cell types. We concentrated
on the human visceral region, homeostatic nutrient balance and cross-talking
phenomena involving hepatocytes, endothelial cells and adipocytes. We validated
our model against experimental data concerning glucose, fatty acid and glycerol
trends. To the best of our knowledge, the in silico model presented here is the first
one to consider the effect of the flow on the co-existence of multiple cell types.
The metabolic network implemented may be extended, comprising other organs
with a key role for energy metabolism, such as pancreas, or adding new aspects,
such as lactate metabolism or hormonal regulation. A regulation model for
genetic expression should be introduced to make the system more adaptable to
exogenous and endogenous stimuli, therefore overcoming the fixity of kinetic
parameter values during simulations. Hybrid approaches may be attempted,
integrating optimization algorithms for parameter estimation and energy
constraints for cells.
Supporting Information
S1 Figure. The graphical interface allowing the user to introduce or not the
presence of the culture medium flow in the simulated model. The mask of
subsystem ‘‘Input Data’’ through which the user can set the binary value (0 or 1)
of the pop-up variable created to distinguish the static (A) from the dynamic (B)
culture conditions for cell monocultures. It is followed by a screenshot (C) of a
Matlab file (.m) showing the association of the pop-up variable value to a set of
initialization values for enzymatic parameters.
doi:10.1371/journal.pone.0111946.s001 (TIF)
S2 Figure. Measured [23] and simulated glycerol trends in the culture medium
for hepatic monocultures. Upper figure refers to static conditions, the other one
describes dynamic conditions. Solid line represents the simulated data, while
circles (for the static case) and squares (for the dynamic case) represent the
corresponding experimental data. Measured values are expressed as means ¡
standard deviation for experiments run at least in triplicate: numerical values are
reported in [23] and error bars represent the standard deviation. (A) Glycerol
trend in static conditions. (B) Glycerol trend in dynamic conditions.
doi:10.1371/journal.pone.0111946.s002 (TIF)
S3 Figure. Measured [23] and simulated glycerol trends in the culture medium
for adipose monocultures. Upper figure refers to static conditions, the other one
describes dynamic conditions. Solid line represents the simulated data, while
circles (for the static case) and squares (for the dynamic case) represent the
corresponding experimental data. Measured values are expressed as means ¡
standard deviation for experiments run at least in triplicate: numerical values are
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reported in [23] and error bars represent the standard deviation. (A) Glycerol
trend in static conditions. (B) Glycerol trend in dynamic conditions.
doi:10.1371/journal.pone.0111946.s003 (TIF)
S1 Table. The full list of all enzymes and consumption terms used in the
modelling with their corresponding equations. In reaction kinetics (both in
equilibrium and non-equlibrium conditions), oxidated-form cofactors (NAD+,
FAD, ADP, NADP+) are considered in saturation, then they not play an active
role on the regulation of catalysis rates. It is a good approximation, in fact they are
in large quantity in cells. Enzymatic parameters: Km for direct Kmdð Þ and indirect
Kmið Þ reactions, Ki for inhibitors, Vmax for direct Vmaxd and indirect Vmaxi
reactions.
doi:10.1371/journal.pone.0111946.s004 (DOCX)
S2 Table. The full list of state equations used in the modelling.
doi:10.1371/journal.pone.0111946.s005 (DOCX)
S3 Table. The full list of stoichiometric equations used in the modelling for
aminoacid degradation.
doi:10.1371/journal.pone.0111946.s006 (DOCX)
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